Immediate Impact
1 by Nobel laureates 24 standout
Citing Papers
Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets
2024 Standout
Tumor biomarkers for diagnosis, prognosis and targeted therapy
2024 Standout
Works of Jim Wright being referenced
Clinical trials referral resource. Current clinical trials for the proteasome inhibitor PS-341.
2000
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jim Wright | 18 | 25 | 6 | 21 | 12 | 65 | |
| Sean Michael Morris | 16 | 17 | 22 | 14 | 169 | ||
| Caroline Whiting | 3 | 31 | 2 | 47 | 11 | 171 | |
| Robert L. Gibson | 3 | 53 | 44 | 20 | 14 | 168 | |
| Marisa Helena César Coral | 25 | 7 | 7 | 1 | 8 | 191 | |
| Shefali Setia-Verma | 13 | 3 | 5 | 3 | 10 | 185 | |
| Kara D. Brodie | 4 | 5 | 6 | 2 | 11 | 68 | |
| Soujanya Kaup | 4 | 58 | 47 | 6 | 9 | 168 | |
| Christopher King | 3 | 8 | 1 | 3 | 16 | 183 | |
| Rebecca McGraw | 45 | 55 | 10 | 15 | 163 | ||
| Laurie Anderson | 11 | 5 | 3 | 10 | 47 |
All Works
Login with ORCID to disown or claim papers
Loading papers...